ArticleAlimentary pharmacology & therapeutics2022

Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring study.

Neil Chanchlani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.